semaglutide patent expiration us 2031 weight-loss drug has expired in India, Indian pharmaceutical has wasted no-time to announce generics. What is the most pressing concern about semaglutide generics in India? ✅️Use without prescription is risky As the patent for semaglutide,

Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking semaglutide.

This drug, indicated for glycemic control in patients aged 10 years and above with type 2 diabetes, serves as an adjunct to diet and exercise

However, that is not the reality: even diabetic patients treated with GLP-1 RAs are more likely to stop them than other second-line anti-diabetic medicines.3 That study didnt report why 50% of diabetics on GLP-1 RAs discontinued them, but gastrointestinal (GI) adverse events were a suggested cause.3 Adverse events are just one of a number of reasons that people stop using these drugs, as follows.

Reduce hair fall by 30% in two months, and stimulate hair follicle growth by 200%